Publication|Articles|May 15, 2026
- Pharmaceutical Executive: May 2026
- Volume 46
- Issue 4
Pharmaceutical Executive: May 2026 Interactive Digital Edition
View the Pharmaceutical Executive May 2026 issue in an interactive format.
Advertisement
Articles in this issue
4 months ago
Model Examples4 months ago
John Oyler: Rewiring Operations in Oncology4 months ago
Pharmaceutical Risks in the Strait of HormuzAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report
2
Eli Lilly to Acquire Merida Biosciences for $2.8 Billion
3
The Future Relationship Between AI and Field Reps
4
BioNTech Terminates Phase II Clinical Trial for Cevumeran
5
